Concepedia
Statistics
Publications
2
Citations
36
H-Index
Active since
2022
M S. ROBERTS is an author specializing in endocrine pharmacotherapy, glucagon receptor agonism, and clinical pharmacology.
Publications per year
2022–2024
334-OR: Pemvidutide (ALT-801) , a Balanced (1:1) GLP-1/Glucagon Dual Receptor Agonist, Induces Rapid and Marked Weight Loss without the Need for Dose Titration in People with Overweight/Obesity
SAMUEL KLEIN, JOHN J. NESTOR, M. SCOTT HARRIS et al. · Diabetes · 2022 · 21 citations
Medicine, Pharmacology, Pharmacotherapy +17
262-OR: Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, in Subjects with Overweight or Obesity—A 48-Week, Placebo-Controlled, Phase 2 (MOMENTUM) Trial
Louis J. Aronne, M. SCOTT HARRIS, M S. ROBERTS et al. · Diabetes · 2024 · 15 citations
Pharmacy, Endocrinology, Pharmacology +17
1–2 of 2